{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:28:00Z","timestamp":1791329280193,"version":"4.3.1"},"reference-count":186,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/pat.0b013e32835f2264","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T13:11:51Z","timestamp":1362748311000},"page":"229-242","source":"Crossref","is-referenced-by-count":105,"title":["Precursors and pathogenesis of ovarian carcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"D.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32835f2264_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0010","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0015","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/0046-8177(92)90393-H","article-title":"Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur?","volume":"23","author":"Powell","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-8258(92)90075-T","article-title":"Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcino-ma","volume":"47","author":"Puls","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0030","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Ann Rev Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2010.07.026","article-title":"A critical re-appraisal of BRCA1 methylation studies in ovarian cancer","volume":"119","author":"Senturk","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00428-010-0979-4","article-title":"Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases","volume":"457","author":"Maeda","year":"2010","journal-title":"Virchows Archiv"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajog.2004.02.067","article-title":"Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause","volume":"191","author":"Piek","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","article-title":"Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data","volume":"23","author":"Gilks","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.1521","article-title":"In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours","volume":"202","author":"Sieben","year":"2004","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0085","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004347-200301000-00009","article-title":"Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor)","volume":"22","author":"Singer","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0100","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/CCO.0b013e32833b0dc1","article-title":"The pathology of and controversial aspects of ovarian borderline tumours","volume":"22","author":"McCluggage","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/gyno.2000.6066","article-title":"K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary","volume":"80","author":"Alvarez","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004280050314","article-title":"In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential","volume":"434","author":"Haas","year":"1999","journal-title":"Virchows Archiv"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","article-title":"KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants","volume":"103","author":"Mayr","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0145","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0150","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","article-title":"Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/hupa.2002.30212","article-title":"Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas","volume":"33","author":"Staebler","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2010.01.006","article-title":"Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary","volume":"117","author":"May","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis","volume":"31","author":"Dehari","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.2001.01042.x","article-title":"Precursor lesions of ovarian epithelial malignancy","volume":"38","author":"Feeley","year":"2001","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0175","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006254-197203000-00001","article-title":"The secondary Mullerian system","volume":"27","author":"Lauchlan","year":"1972","journal-title":"Obstet Gynecol Surv"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0090-8258(90)90053-N","article-title":"Primary paraovarian cystadeno-carcinoma: clinical and management aspects and literature review","volume":"38","author":"Altaras","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1048-891X.2004.14428.x","article-title":"Paraovarian tumor of borderline malignancy-a case report","volume":"14","author":"De Areia","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0195","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0200","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0205","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary","volume":"65","author":"Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0210","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma","volume":"12","author":"Davidson","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0215","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","article-title":"Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas","volume":"69","author":"Kuo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0220","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijc.20408","article-title":"Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy","volume":"112","author":"Santin","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0230","series-title":"Atlas of Tumor Pathology","first-page":"125","article-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament","author":"Scully","year":"1998"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0235","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Breast and Female Genital Organs","author":"Tavassoli","year":"2003"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004347-200210000-00010","article-title":"Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study","volume":"21","author":"Mhawech","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(03)00047-2","article-title":"Prevalence of endometriosis in malignant epithelial ovary tumours","volume":"109","author":"Oral","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00313027909063533","article-title":"The pathological assessment of ovarian neoplasms. I: Introduction to the common \u2018epithelial\u2019 tumours and analysis of benign \u2018epithelial\u2019 tumours","volume":"11","author":"Russell","year":"1979","journal-title":"Pathology"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004347-200104000-00004","article-title":"Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types","volume":"20","author":"Stern","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0260","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/cncr.10566","article-title":"Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts","volume":"94","author":"Nezhat","year":"2002","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0090-8258(02)00104-X","article-title":"Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach","volume":"88","author":"Horiuchi","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0280","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0285","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0290","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0300","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0305","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1006\/gyno.2002.6674","article-title":"Specific keynote: hereditary ovarian cancer: what we know","volume":"88","author":"Boyd","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0310","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0315","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0320","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jnci\/90.11.841","article-title":"Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations","volume":"90","author":"Schorge","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0325","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0330","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0340","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0345","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase","volume":"23","author":"Sehdev","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes","volume":"34","author":"Wei","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0355","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0365","doi-asserted-by":"crossref","first-page":"176675","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0370","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0380","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist\u2019s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0385","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0390","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1093\/oxfordjournals.aje.a113523","article-title":"Events of reproductive life and the incidence of epithelial ovarian cancer","volume":"117","author":"Risch","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0395","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PGP.0b013e31824ae6f2","article-title":"Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases","volume":"31","author":"Garg","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0400","first-page":"663","article-title":"Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma","volume":"10","author":"Silva","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0405","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0410","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","volume":"110","author":"Salvador","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0415","first-page":"625","article-title":"STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis","volume":"3","author":"Mehra","year":"2011","journal-title":"Frontiers Biosci"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0420","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mpdhp.2008.06.009","article-title":"Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low-and high-grade disease and the role of the fallopian tube","volume":"14","author":"Carlson","year":"2008","journal-title":"Diagn Histopathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0425","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0430","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk factors for a serous cancer precursor (\u2018p53 signature\u2019) in women with inherited BRCA mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0435","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0440","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0445","first-page":"249","article-title":"Ovarian atypical endometriosis: its close association with malignant epithelial tumours","volume":"30","author":"Fukunaga","year":"1997","journal-title":"Histo-pathology"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0450","first-page":"1023","article-title":"Malignant neoplasms arising in endometriosis","volume":"75","author":"Heaps","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0455","first-page":"537","article-title":"Ovarian carcinoma arising in atypical endometriosis","volume":"75","author":"Moll","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0460","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/gyno.1996.0032","article-title":"Histologic transformation of benign endometriosis to early epithelial ovarian cancer","volume":"60","author":"Sainz de la Cuesta","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/00016347109157288","article-title":"Carcinoma of the ovary and endometriosis","volume":"50","author":"Aure","year":"1971","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0020-7292(97)00238-5","article-title":"Prevalence of ovarian endometriosis in epithelial ovarian cancer","volume":"59","author":"Jimbo","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0475","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/gyno.2000.5765","article-title":"Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study","volume":"77","author":"Ogawa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0480","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00003081-198023030-00024","article-title":"Malignant tumors arising in endometriosis","volume":"23","author":"Mostoufizadeh","year":"1980","journal-title":"Clin Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000478-198503000-00004","article-title":"Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases","volume":"9","author":"Bell","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0490","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00000478-198809000-00002","article-title":"Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases","volume":"12","author":"Snyder","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0495","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0500","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0020-7292(03)00340-0","article-title":"Familial risk among Japanese patients with endometriosis","volume":"84","author":"Kashima","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0505","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0015-0282(02)03341-1","article-title":"The International Endogene Study: a collection of families for genetic research in endometriosis","volume":"78","author":"Treloar","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0510","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/432960","article-title":"Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26","volume":"77","author":"Treloar","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"10.1097\/PAT.0b013e32835f2264_bib0515","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000052878","article-title":"Molecular genetic defects in endometriosis","volume":"50","author":"Thomas","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0520","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/humupd\/dmp034","article-title":"The role of microRNAs in endometriosis and associated reproductive conditions","volume":"16","author":"Teague","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0530","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/molehr\/gan033","article-title":"Potential involvement of iron in the pathogenesis of peritoneal endometriosis","volume":"14","author":"Defrere","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0535","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mrfmmm.2003.08.023","article-title":"Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal","volume":"533","author":"Huang","year":"2003","journal-title":"Mutat Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590802366204","article-title":"The role of iron in the pathogenesis of endometriosis","volume":"25","author":"Kobayashi","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0545","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0550","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mob.2003.408","article-title":"Endometriosis and ovarian cancer: thoughts on shared pathophysiology","volume":"189","author":"Ness","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0555","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0015-0282(02)02959-X","article-title":"Oxidative stress and peritoneal endometriosis","volume":"77","author":"Van Langendonckt","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0560","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/PGP.0b013e31821f4b85","article-title":"Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects","volume":"30","author":"Wei","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0565","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1078-0432.CCR-07-1614","article-title":"Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress","volume":"14","author":"Yamaguchi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0570","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9378(93)90159-G","article-title":"Endometriosis and ovarian cancer","volume":"169","author":"Vercellini","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0580","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pgp.0000192274.44061.36","article-title":"Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis","volume":"25","author":"Ali-Fehmi","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0585","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0090-8258(90)90288-V","article-title":"Nucleolar organizer regions in endometriosis, atypical endometriosis, and clear cell and endometrioid carcinomas","volume":"40","author":"Chalas","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0590","first-page":"318","article-title":"A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes","volume":"53","author":"Czernobilsky","year":"1979","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0595","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0046-8177(88)80090-X","article-title":"Ovarian tumors associated with atypical endometriosis","volume":"19","author":"LaGrenade","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0600","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0002-9440(10)65206-6","article-title":"Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract","volume":"155","author":"Ogawa","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bpobgyn.2003.03.001","article-title":"Endometriosis and the development of malignant tumours of the pelvis. A review of literature","volume":"18","author":"Van Gorp","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0610","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcp\/102.4.415","article-title":"Ovarian endometriotic cysts. An analysis of cytologic atypia and DNA ploidy patterns","volume":"102","author":"Ballouk","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0615","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/gyno.2001.6529","article-title":"Epithelial abnormalities in cystic ovarian endometriosis","volume":"84","author":"Prefumo","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0620","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IGC.0b013e318231f140","article-title":"Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers","volume":"22","author":"Lowery","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0625","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.10715","article-title":"Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis","volume":"102","author":"Martini","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0630","first-page":"2095","article-title":"Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors","volume":"58","author":"Obata","year":"1998","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0635","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ijc.21845","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"119","author":"Prowse","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0640","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2004.07.019","article-title":"Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas","volume":"35","author":"Catasus","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0645","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Campbell","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0650","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00019606-200106000-00008","article-title":"beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas","volume":"10","author":"Moreno-Bueno","year":"2001","journal-title":"Diagn Mol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0655","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1088::AID-CNCR12>3.0.CO;2-2","article-title":"K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients","volume":"82","author":"Cuatrecasas","year":"1998","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0660","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/path.1923","article-title":"High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary","volume":"208","author":"Oliva","year":"2006","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0665","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0b013e3181a902e1","article-title":"Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases","volume":"33","author":"Geyer","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0670","doi-asserted-by":"crossref","first-page":"32133","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/beta-catenin and PI3K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0675","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","article-title":"Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010","volume":"121","author":"Anglesio","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0680","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-8258(89)90637-9","article-title":"Ovarian clear cell adenocarcinoma","volume":"32","author":"Kennedy","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0685","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","article-title":"Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases","volume":"33","author":"Veras","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0690","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0695","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0700","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0705","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IGC.0b013e31826b5dcc","article-title":"Loss ofARID1A expressionis an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma","volume":"22","author":"Ayhan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0710","first-page":"642","article-title":"Loss of ARID1A\/BAF250a expression in ovarian endometriosis and clear cell carcinoma","volume":"5","author":"Xiao","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0715","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma","volume":"174","author":"Kuo","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0720","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2007.03.041","article-title":"Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma","volume":"106","author":"Lee","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0725","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/onc.2009.470","article-title":"Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes","volume":"29","author":"Yamaguchi","year":"2010","journal-title":"Oncogene"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0730","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary","volume":"33","author":"Kobel","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0735","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0740","first-page":"e232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"Public Library Sci Med"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0745","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"Kobel","year":"2010","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0750","first-page":"177","article-title":"Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II","volume":"26","author":"Skirnisdottir","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0755","first-page":"6538","article-title":"Mechanisms of chemoresistance and poorprognosis in ovarian clear cell carcinoma","volume":"99","author":"Itamochi","year":"2008","journal-title":"CancerSci"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0760","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0765","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas","volume":"29","author":"Kobel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0770","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0775","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(195403)7:2<302::AID-CNCR2820070214>3.0.CO;2-9","article-title":"Mucinous cystadenomas and mucinous cysta-denocarcinomas of the ovary; a clinical and pathological study of 355 cases","volume":"7","author":"Cariker","year":"1954","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0780","first-page":"699","article-title":"Mucinous tumors of the ovary","volume":"16","author":"Woodruff","year":"1960","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0785","series-title":"Atlas of Tumor Pathology. Tumors of the Female Sex Organs. Part 3, Tumors of the Ovary and Fallopian Tube. Section IX, Fascicle 3","author":"Hertig","year":"1961"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0790","first-page":"181","article-title":"Morphologic precursors of ovarian epithelial tumors","volume":"82","author":"Resta","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0795","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0800","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1471-0528.1956.tb05477.x","article-title":"A note on the origin of the pseudomucinous cystadenoma of the ovary","volume":"63","author":"Towers","year":"1956","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0805","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U","article-title":"Ovarian mullerian mucinous papillary cystade-nomas of borderline malignancy. A clinicopathologic analysis","volume":"61","author":"Rutgers","year":"1988","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0810","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/PGP.0b013e31823f8482","article-title":"Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARTD1A","volume":"31","author":"Wu","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0815","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00000478-199812000-00002","article-title":"Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up","volume":"22","author":"Hoerl","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0820","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with \u2018pseudomyxoma peritonei\u2019","volume":"24","author":"Lee","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0825","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1440-1827.1997.tb03718.x","article-title":"A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors","volume":"47","author":"Nomura","year":"1997","journal-title":"Pathol Int"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0830","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.5858\/132.11.1753","article-title":"Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors","volume":"132","author":"Seidman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0835","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/gyno.1999.5402","article-title":"Well-differentiated mucinous carcinoma of the ovary and a coexisting Brenner tumor both exhibit amplification of 12q14-21 by comparative genomic hybridization","volume":"74","author":"Pejovic","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0840","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000478-199903000-00012","article-title":"Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors","volume":"23","author":"Caduff","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0845","first-page":"777","article-title":"K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary","volume":"139","author":"Enomoto","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0850","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0855","first-page":"33","article-title":"Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors","volume":"54","author":"Tchikawa","year":"1994","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0860","first-page":"1489","article-title":"Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy","volume":"53","author":"Mok","year":"1993","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0865","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2559.2010.03673.x","article-title":"Endocervical-like (Mullerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation","volume":"57","author":"Kim","year":"2010","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0870","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.4088","article-title":"Molecular characterization of mucinous ovarian tumors supports a stratified treatment approach with HER2 targeting in 18% of carcinomas","volume":"229","author":"Anglesio","year":"2013","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0875","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/jclinpath-2011-200082","article-title":"Dual-colour HER2\/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours","volume":"64","author":"Yan","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0880","first-page":"216A","article-title":"Primary ovarian mucinous tumors (OMT) lack loss of MLH-1 and MGMT and are characterized by KRAS mutations and aberrant p53 expression when they progress to carcinoma","volume":"22","author":"Gupta","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0885","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e318188b84c","article-title":"Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas","volume":"33","author":"Cuatrecasas","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0890","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/00000478-200311000-00005","article-title":"Tmmunoprofile of ovariantumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications","volume":"27","author":"Logani","year":"2003","journal-title":"Am JSurg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0895","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s004280000315","article-title":"Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins","volume":"438","author":"Riedel","year":"2001","journal-title":"Virchows Archiv"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0900","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PGP.0b013e31824d7445","article-title":"Transitional Cell Carcinoma of the Ovary is Related to High-grade Serous Carcinoma and is Distinct From Malignant Brenner Tumor","volume":"31","author":"Ali","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0905","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajcp\/109.2.173","article-title":"Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4)","volume":"109","author":"Costa","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0910","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000478-200404000-00004","article-title":"Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis","volume":"28","author":"Eichhorn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0915","first-page":"457","article-title":"Ovarian carcinomas with transitional cell carcinoma pattern","volume":"93","author":"Silva","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0920","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1097-0142(19801215)46:12<2617::AID-CNCR2820461214>3.0.CO;2-M","article-title":"Histogenesis of Brenner tumors, II: histochemistry and CEA","volume":"46","author":"Shevchuk","year":"1980","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0925","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/1097-0142(197905)43:5<1830::AID-CNCR2820430536>3.0.CO;2-C","article-title":"Pure and mixed Brenner tumors of the ovary: clinicopathologic and histogenetic observations","volume":"43","author":"Waxman","year":"1979","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32835f2264_bib0930","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T16:12:00Z","timestamp":1644509520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516315641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":186,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0031302516315641"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32835f2264","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}